Literature DB >> 29552175

Modification of the method to establish a hepatic VX2 carcinoma model in rabbits.

Huan Tong1,2, Li-Geng Duan3, Hong-Ying Zhou1, Shi Feng1.   

Abstract

The hepatic VX2 carcinoma model in rabbits is widely used for the preclinical study of hepatocellular carcinoma. In the present study, a modification was made to the conventional method to establish the animal model, as the conventional method gives rise to frequent tumor seeding due to the drop-out of tumor fragments. In order to evaluate each distinct method of establishing the model, the rabbits were divided into two groups: Group A (the conventional method; n=20) and group B (the modified method; n=20). All surgical details were recorded for reference. At 14 days post-surgery, contrast-enhanced computed tomography (CECT) and autopsy were conducted. Microscopic morphology of tumor cells was observed using hematoxylin and eosin (H&E) and transmission electron microscopy (TEM). Vascular endothelial growth factor (VEGF) and cluster of differentiation (CD)31 were detected via immunochemistry and reverse transcription-polymerase chain reaction. In total, 19 rabbits in each group succeeded in model establishment. Throughout the surgery, group A experienced a longer surgery time compared with group B (group A vs. group B, 22.57±1.34 vs. 20.17±1.50 min; P<0.001), an increased tumor fragment drop-out frequency (group A vs. group B, 1.84±0.96 vs. 1.16±0.38; P=0.008) and an increased peritoneal nodule incidence (group A vs. group B, 35 vs. 5%, P=0.042). As for CECT, H&E and TEM, hepatic VX2 allografts in the two groups demonstrated similar imaging presentations and tumor cell morphology. In addition, VEGF and CD31 levels did not differ between the two groups. In conclusion, the modified method for the establishment of hepatic VX2 carcinoma model in rabbits may decrease tumor fragment drop-out frequency during surgery and incidence of tumor seeding without affecting the properties of VX2 carcinoma.

Entities:  

Keywords:  VX2 carcinoma; animal model; gelatin sponge; liver neoplasm; method modification

Year:  2018        PMID: 29552175      PMCID: PMC5840741          DOI: 10.3892/ol.2018.7980

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  19 in total

Review 1.  Current status of hepatocellular carcinoma treatment in Japan: transarterial chemoembolization.

Authors:  Osamu Matsui
Journal:  Clin Drug Investig       Date:  2012-08-08       Impact factor: 2.859

2.  Angiogenesis dependent characteristics of tumor observed on rabbit VX2 hepatic carcinoma.

Authors:  Liming Guan
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Comparison of two different laparotomy methods for modeling rabbit VX2 hepatocarcinoma.

Authors:  Zhu Chen; Zhen Kang; En-Hua Xiao; Min Tong; Yu-Dong Xiao; Hua-Bing Li
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

Review 4.  Loco-regional treatment of HCC: current status.

Authors:  L Crocetti; I Bargellini; R Cioni
Journal:  Clin Radiol       Date:  2017-02-28       Impact factor: 2.350

Review 5.  Hepatocellular carcinoma: Where there is unmet need.

Authors:  Manojkumar Bupathi; Ahmed Kaseb; Funda Meric-Bernstam; Aung Naing
Journal:  Mol Oncol       Date:  2015-06-25       Impact factor: 6.603

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

7.  Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allografts.

Authors:  Huan Tong; Xiao Li; Chun Le Zhang; Jin Hang Gao; Shi Lei Wen; Zhi Yin Huang; Fu Qiang Wen; Ping Fu; Cheng Wei Tang
Journal:  J Dig Dis       Date:  2013-01       Impact factor: 2.325

8.  Stimulation of tumor growth in vitro and in vivo by suramin on the VX2 model.

Authors:  L H Ramirez; M Juliéron; M Bonnay; S Koscielny; Z Zhao; A Gouyette; J N Munck
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

9.  Percutaneous ultrasound guided implantation of VX2 for creation of a rabbit hepatic tumor model.

Authors:  Sarah B White; Jeane Chen; Andrew C Gordon; Kathleen R Harris; Jodi R Nicolai; Derek L West; Andrew C Larson
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

10.  CANCERS DERIVING FROM THE VIRUS PAPILLOMAS OF WILD RABBITS UNDER NATURAL CONDITIONS.

Authors:  J G Kidd; P Rous
Journal:  J Exp Med       Date:  1940-03-31       Impact factor: 14.307

View more
  1 in total

1.  Establishment of a modified percutaneous CT-guided paraspinal intramuscular VX-2 squamous cell carcinoma dual tumor model in rabbits.

Authors:  Liangliang Meng; Husheng Shan; Xiaofeng He; Jiantao Zhou; Jingxiang Huang; Xin Zhang; Li Ma; Xiaodong Xue; Zhongliang Zhang; Yueyong Xiao
Journal:  PeerJ       Date:  2021-05-28       Impact factor: 2.984

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.